Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PETMED EXPRESS, INC.

(PETS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

PetMed Express Shares Lower After Morgan Stanley Begins Coverage at Underweight

11/18/2021 | 11:36am EST


ę MT Newswires 2021
All news about PETMED EXPRESS, INC.
01/21NORTH AMERICAN MORNING BRIEFING : Dow Wobbles, -3-
DJ
01/20Sidoti Upgrades PetMed Express to Buy From Neutral; Price Target is $32
MT
01/19PETMED EXPRESS : PetMeds To Announce Its Third Quarter Financial Results On January 24, 20..
PU
01/18PETMED EXPRESS : PetMeds« To Announce Its Third Quarter Financial Results On January 24, 2..
PU
01/18PETMED EXPRESS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
01/18PetMeds« To Announce Its Third Quarter Financial Results On January 24, 2022
AQ
01/18NORTH AMERICAN MORNING BRIEFING : Bond Yields Hit -3-
DJ
01/11PETMED EXPRESS : Press release dated January 10, 2022 - Form 8-K
PU
01/11PETMED EXPRESS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
01/10PetMeds« Appoints Three New Key Executives
GL
More news
Analyst Recommendations on PETMED EXPRESS, INC.
More recommendations
Financials (USD)
Sales 2022 284 M - -
Net income 2022 23,4 M - -
Net cash 2022 115 M - -
P/E ratio 2022 21,1x
Yield 2022 5,08%
Capitalization 485 M 485 M -
EV / Sales 2022 1,30x
EV / Sales 2023 1,22x
Nbr of Employees 219
Free-Float -
Chart PETMED EXPRESS, INC.
Duration : Period :
PetMed Express, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PETMED EXPRESS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 24,01 $
Average target price 27,67 $
Spread / Average Target 15,2%
EPS Revisions
Managers and Directors
Matthew N. Hulett President, Chief Executive Officer & Director
Bruce S. Rosenbloom Chief Financial Officer & Treasurer
Gian Mark Fulgoni Chairman
Mark Moseley Chief Technology & Information Officer
Ronald J. Korn Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PETMED EXPRESS, INC.-4.95%485
RAIA DROGASIL S.A.-13.54%6 388
AIN HOLDINGS INC.0.70%1 781
RITE AID CORPORATION-28.11%572
QOL HOLDINGS CO., LTD.-6.36%423
HLS THERAPEUTICS INC.-0.33%387